Recent and archived news stories on: biotechnology, pharmaceutical companies, health insurance companies, hospitals, medical devices, medical groups

Puma Shares Slip as Sales of Cancer Drug Fall

Shares of Pasadena-based Puma Biotechnology Inc. fell after the company revealed that sales of its breast cancer treatment drug, Nerlynx, declined during the fourth quarter.

Tease photo

Herbalife Sees Coronavirus Impact

Company anticipates disruption in operations for quarter, year

Count downtown-based nutrition supplement company Herbalife Nutrition Ltd. as another company feeling the impact of the rapid spread of the Covid-19 coronavirus throughout China.

Tease photo

OC’s Hoag Moves Into LA County

Institute acquires surgery center in Marina del Rey

Hoag Memorial Hospital Presbyterian, one of Orange County’s largest hospital and health care networks, is entering the Los Angeles County market.

Tease photo

ChromaDex Expands Pact

Nestlé service will boost company’s supplement

The world’s largest food and beverage company has agreed to flex more of its marketing muscle for a product from Westwood-based nutrition company ChromaDex Inc.

Tease photo

FDA Gives Kite Cellular Drug Therapy Fast Track Designation

The FDA must decide within six months whether to approve the drug, known as KTE-X19

Tease photo

Xencor to License Food Allergy Drug

Deal with Aimmune could bring up to $400 million before royalties

Monrovia-based biopharmaceutical company Xencor Inc. announced it has granted a license to Bay Area-based Aimmune Therapeutics Inc.

Tease photo

Molina Expects Positive Results Ahead

Managed care insurer projects $17 billion in revenue for 2020

With the release of fourth-quarter and full-year 2019 earnings, Molina issued a forecast of premium revenue growth for this year of 7.4% to about $17.4 billion.

Tease photo

Puma Shares Soar 81% Over 2 Days

Biotechnology company stays quiet amid speculation about run-up

After a year of lackluster and disappointing performance, shares of Westwood-based biopharmaceutical company Puma Biotechnology Inc. mysteriously shot up 81% Feb. 4 and 5 on some of its heaviest trading volume in years.

Tease photo

Arrowhead announces 'promising' clinical trial results

Arrowhead Pharmaceuticals Inc. announced Feb. 5 that it had achieved “promising” interim results from early clinical trials for two of its drugs

Tease photo

NantHealth Stock Surges Again on News

Investors respond to promising AI test, software partnership

After months of relatively little news from billionaire Patrick Soon-Shiong’s Culver City-based network of health care businesses, the past few weeks have brought multiple developments that sent shares soaring.

Tease photo

RadNet Offering Cancer Treatment

Sets deal with Canadian medical device company

Sawtelle-based diagnostic imaging services company RadNet Inc. said it will explore entering the cancer treatment business.

Tease photo

EU OK’s Synedgen

Company wins patent for inflammation drug

Claremont-based biotech company Synedgen Inc. has been granted a European Union patent for its drug to treat GI inflammation related to cancer treatment.

Health Meets Wealth

Health Care: Arrowhead and Prospect Medical could give sector a shot in the arm

The Los Angeles health care market has seen a trend toward fewer but bigger deals in the last few years, and 2020 could bring more of the same.

Tease photo

Huntington Medical Research Institutes Awarded $1 Million Grant for Brain Research

Pasadena-based Huntington Medical Research Institutes has received a $1 million, three-year award from the W.M. Keck Foundation for brain research.

Tease photo

Ritter Pharmaceuticals to Be Acquired by Qualigen

Century City-based Ritter Pharmaceuticals Inc., which makes drugs to treat gastrointestinal diseases, is being acquired in a reverse merger with Carlsbad-based cancer therapy firm Qualigen Inc.

Tease photo